Secondary ANLL with t(11;19)(q23;p13) following etoposide and cisplatin for ovarian germ cell tumor

Indian J Cancer. 1997 Jun;34(2):84-7.

Abstract

This is a case report of a ten year old girl with ovarian germ cell tumor who was successfully treated with BEP chemotherapy. She developed acute myloid leukemia, AML-M5 with t(11;19)(q23;p13), 29 months after being off therapy. She received a cumulative dose of 2000 mg/m2 of etoposide and 400 mg/m2 of cisplatin. The association of etoposide and therapy related leukemia is reviewed.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Child
  • Chromosomes, Human, Pair 11*
  • Chromosomes, Human, Pair 19
  • Cisplatin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Germinoma / complications
  • Germinoma / drug therapy*
  • Germinoma / genetics
  • Humans
  • Leukemia, Myeloid, Acute / chemically induced*
  • Leukemia, Myeloid, Acute / genetics
  • Ovarian Neoplasms / complications
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics
  • Translocation, Genetic*

Substances

  • Etoposide
  • Cisplatin